L

Lineage Cell Therapeutics Inc
TASE:LCTX

Watchlist Manager
Lineage Cell Therapeutics Inc
TASE:LCTX
Watchlist
Price: 350 ILS 11.79% Market Closed
Market Cap: 176.1m ILS

Relative Value

The Relative Value of one LCTX stock under the Base Case scenario is hidden ILS. Compared to the current market price of 350 ILS, Lineage Cell Therapeutics Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LCTX Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
63
vs Industry
73
Median 3Y
5.5
Median 5Y
6.1
Industry
7.1
Forward
6.4
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2.1
Industry
22.9
Forward
-2.6
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-2
Industry
19.4
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1
Industry
22.6
vs History
71
vs Industry
74
Median 3Y
0.8
Median 5Y
0.9
Industry
2.7
vs History
vs Industry
29
Median 3Y
0.6
Median 5Y
1.1
Industry
7.4
Forward
0.6
vs History
vs Industry
26
Median 3Y
0.7
Median 5Y
1.2
Industry
9.2
vs History
33
vs Industry
18
Median 3Y
-0.3
Median 5Y
-0.4
Industry
4.5
Forward
-0.2
vs History
33
vs Industry
16
Median 3Y
-0.3
Median 5Y
-0.4
Industry
4.5
Forward
-0.2
vs History
36
vs Industry
21
Median 3Y
-0.4
Median 5Y
-0.5
Industry
5
vs History
36
vs Industry
17
Median 3Y
-0.4
Median 5Y
-0.5
Industry
3.7
vs History
vs Industry
45
Median 3Y
0.1
Median 5Y
0.2
Industry
4.9

Multiples Across Competitors

LCTX Competitors Multiples
Lineage Cell Therapeutics Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Lineage Cell Therapeutics Inc
TASE:LCTX
176.1m ILS 5.6 -3.3 -0.3 -0.2
FR
Pharnext SCA
OTC:PNEXF
6T USD 33 710 712 -160 222 -194 560.6 -192 340.5
US
Abbvie Inc
NYSE:ABBV
334.3B USD 5.8 80.5 15.3 22.6
US
Amgen Inc
NASDAQ:AMGN
160.4B USD 4.7 27 14.5 23.9
US
Gilead Sciences Inc
NASDAQ:GILD
139.1B USD 4.8 23.3 10.1 14
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
118.1B USD 10.6 -119.4 25.4 26.6
US
Epizyme Inc
F:EPE
94.1B EUR 2 089.8 -533.3 -580.7 -565.2
AU
CSL Ltd
ASX:CSL
116.7B AUD 5 27.9 17.2 21.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
59.2B USD 4.2 13.2 11.8 13.2
US
Seagen Inc
F:SGT
39.3B EUR 20.1 -61.7 -66.6 -60.1
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
43.3B USD 18.4 -160.4 -720.3 -361
P/E Multiple
Earnings Growth PEG
US
L
Lineage Cell Therapeutics Inc
TASE:LCTX
Average P/E: 34.4
Negative Multiple: -3.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -160 222 N/A N/A
US
Abbvie Inc
NYSE:ABBV
80.5
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
27
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
23.3
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -119.4 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -533.3 N/A N/A
AU
CSL Ltd
ASX:CSL
27.9
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
7%
1.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -61.7 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -160.4 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
L
Lineage Cell Therapeutics Inc
TASE:LCTX
Average EV/EBITDA: 15.7
Negative Multiple: -0.3
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -194 560.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.3
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.5
17%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.4
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -580.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.8
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -66.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -720.3 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
L
Lineage Cell Therapeutics Inc
TASE:LCTX
Average EV/EBIT: 20.3
Negative Multiple: -0.2
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -192 340.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.6
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.9
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
14
11%
1.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.6
17%
1.6
US
E
Epizyme Inc
F:EPE
Negative Multiple: -565.2 N/A N/A
AU
CSL Ltd
ASX:CSL
21.6
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
13.2
11%
1.2
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.1 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -361 N/A N/A